AdvanSix (NYSE:ASIX) Trading Up 0.2% – Should You Buy?

Shares of AdvanSix Inc. (NYSE:ASIX) were up 0.2% on Wednesday . The stock traded as high as $30.63 and last traded at $30.15. Approximately 20,887 shares traded hands during mid-day trading, a decline of 85% from the average daily volume of 139,300 shares. The stock had previously closed at $30.10.

Analyst Ratings Changes

Several research analysts have issued reports on ASIX shares. Piper Sandler increased their target price on shares of AdvanSix from $35.00 to $39.00 and gave the stock an “overweight” rating in a report on Friday, November 8th. StockNews.com upgraded shares of AdvanSix from a “hold” rating to a “buy” rating in a research note on Wednesday, December 4th.

AdvanSix Trading Down 1.2 %

The firm has a market capitalization of $794.98 million, a PE ratio of 21.09 and a beta of 1.73. The company has a quick ratio of 0.62, a current ratio of 1.34 and a debt-to-equity ratio of 0.28. The company’s 50-day simple moving average is $30.53 and its 200 day simple moving average is $27.99.

AdvanSix Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Tuesday, November 12th were given a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 2.15%. The ex-dividend date was Tuesday, November 12th. AdvanSix’s payout ratio is currently 45.39%.

Insider Buying and Selling

In other news, CEO Erin N. Kane sold 5,000 shares of the business’s stock in a transaction dated Friday, November 1st. The stock was sold at an average price of $30.37, for a total value of $151,850.00. Following the completion of the transaction, the chief executive officer now owns 517,795 shares of the company’s stock, valued at $15,725,434.15. The trade was a 0.96 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Christopher Gramm sold 1,951 shares of the company’s stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $32.00, for a total value of $62,432.00. Following the completion of the sale, the insider now owns 43,463 shares in the company, valued at $1,390,816. The trade was a 4.30 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 15,369 shares of company stock worth $474,058 in the last three months. Corporate insiders own 5.60% of the company’s stock.

Institutional Investors Weigh In On AdvanSix

Several hedge funds have recently bought and sold shares of ASIX. Copeland Capital Management LLC purchased a new stake in shares of AdvanSix during the third quarter worth approximately $41,000. Point72 DIFC Ltd purchased a new stake in AdvanSix in the 2nd quarter valued at $34,000. Acadian Asset Management LLC acquired a new stake in shares of AdvanSix in the 2nd quarter worth $36,000. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of AdvanSix during the 2nd quarter worth $51,000. Finally, Allspring Global Investments Holdings LLC purchased a new position in shares of AdvanSix during the 2nd quarter worth $51,000. Hedge funds and other institutional investors own 86.39% of the company’s stock.

AdvanSix Company Profile

AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.